BioSpace News Archive

Policy

Skilled Nursing Facilities Seek Solutions to Address Quality as Interest in Post-Acute Care Transitions is on the Rise

Swisslog Healthcare addresses medication safety and access challenges in long-term care settings through in-facility dispensing technology

October 4, 2018
·
3 min read
Job Trends

Puration Announces Cannabis Cultivation Spinoff and Planned Dividend

Puration, Inc. (USOTC: PURA) (“PURA”) today announced spinning off its cannabis cultivation business.

October 4, 2018
·
2 min read
Business

CCRM Welcomes New Physician to its Northern Virginia Fertility Center

CCRM (Colorado Center for Reproductive Medicine), a global pioneer in fertility science, research and treatment, today announced the addition of Carter Owen, M.D. to its team of award-winning fertility specialists.

October 4, 2018
·
3 min read
Business

IQVIA and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data

IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients.

October 4, 2018
·
4 min read
Genetown

McKesson Sponsors Community Pharmacy Ownership Workshop

According to NCPA, more than 50 percent of past Pharmacy Ownership Workshop participants currently own their own pharmacy.

October 4, 2018
·
3 min read
Drug Development

Lilly’s Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes

Results from a phase 2b clinical trial of Eli Lilly and Company’s (NYSE: LLY) dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA, LY3298176) showed strong and clinically meaningful blood sugar reduction and weight loss in people with type 2 diabetes.

October 4, 2018
·
8 min read
Business

Certis USA Completes New Azadirachtin Production Facility to Meet Growing Demand for Neem-Based Biopesticides

Certis USA has completed construction and start-up of a new azadirachtin formulation and packaging facility located in its factory in Wasco, California.

October 4, 2018
·
2 min read
Drug Development

Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes

All investigated doses met the primary efficacy endpoint defined as a change from baseline in A1C versus placebo after 26 weeks of treatment

October 4, 2018
·
8 min read
Drug Development

Merck’s HIV Therapy DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens

Merck today announced the first presentation of data from the Phase 3 DRIVE-SHIFT trial evaluating a switch of medication to DELSTRIGO™

October 4, 2018
·
12 min read
Deals

Gryphon Investors’ CORA Physical Therapy Acquires Two More Tennessee Clinics

CORA Health Services, Inc. announced today that it recently acquired two outpatient physical therapy companies in Tennessee: Clinton Physical Therapy Center and Associated Therapeutics Inc.

October 4, 2018
·
3 min read